SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1035Regeneron Completes Enrollment for IL-1 Trap Phase 3 Trial in Autoinflammatory Dnigel bates-4/19/2006
1034Sanofi had a pipeline update yesterday morning, and Dr. Le Fur highlighted the VBiotech Jim-2/25/2006
1033Anyone have insight into yesterdays 6% gain? Thanksnfwmate-2/25/2006
1032<<...and the oncology trials run by sanofi-aventis Group) there will be muMiljenko Zuanic-2/2/2006
1031I want to see the data for the following statement: <Patients have shown <Biotech Jim-2/2/2006
1030So far so good. "up to at least 4 weeks" is not yet three months (whoMiljenko Zuanic-2/2/2006
1029Preliminary PI results for VEGF Trap in wet AMD: >>TARRYTOWN, N.Y.--(BUSItuck-2/2/2006
1028<<When Avastin is given off-label in AMD, it has to be prepared by a speciMiljenko Zuanic-1/15/2006
1027<i>>Aventis leakage from vitrea is probably lower than for Lucentis, anDewDiligence_on_SI-1/14/2006
1026<<A black box won’t matter much commercially, IMO. The only treatment thatMiljenko Zuanic-1/14/2006
1025<i>Is 3% [at 0.5mg] for MI/stroke random noise?</i> In this patientDewDiligence_on_SI-1/14/2006
1024Is 3% for MI/stroke random noise? +500 pts is not large number to classify this Miljenko Zuanic-1/14/2006
1023Addendum re Lucentis safety: investorshub.comDewDiligence_on_SI-1/14/2006
1022Lucentis data from ANCHOR study are superb: tinyurl.com It's going to be tDewDiligence_on_SI-1/14/2006
1021lehman - - Jim Birchenough, M.D. and Ajim Tamboli, CFA December 27, 2005 Regensoftware salesperson-12/27/2005
1020Lehman Brothers has upgraded drug maker Regeneron Pharmaceuticals (REGN: RegenerJohn McCarthy-12/27/2005
1019Recently Company announced restructuring (layoff and scaling down clinical progrMiljenko Zuanic-12/23/2005
1018I found this link to an article this morning. Sanofi-Aventis and Regeneron Pharsdbanks892-12/22/2005
1017Just noticed a sharp increase to $11.77 today (12/20/05), but am unable to find jbn3-12/20/2005
1016OT Complexity of the AKT Message 21910800Miljenko Zuanic-11/22/2005
1015Novartis sold (11-08-05) their stake of 7.5 M shares at 11.06!!! Who was buyer?Miljenko Zuanic-11/10/2005
1014Nature Medicine 11, 1188 - 1196 (2005) Akt1 regulates pathological angiogenesiscaram(o)uche-11/8/2005
101316:22 of the presentation...... it's an agonist....... wsw.com (slide 19scaram(o)uche-11/7/2005
1012OT <<Mol Cell Biol. 2002 Mar;22(6):1704-13. The endothelial receptor tyMiljenko Zuanic-11/7/2005
1011into "formal development", expected phase I by end of 2006, beginning scaram(o)uche-11/7/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News